1. US National Archives and Records Administration. Code of federal regulations. IND Content and format. 2013;Title 21, Part 312.23.
2. USFDA Center for Biologics Evaluation and Research. FDA guidance for industry: cGMP for phase 1 investigational drugs. Jul 2008. Available from:
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070273.pdf
3. US National Archives and Records Administration. Code of federal regulations. Human cells, tissues, and cellular and tissue-based products. 2013;Title 21, Part 1271.
4. US Code. Public Health Service Act. Regulation of biological products. 1999;Title 42, Part 262, Section 351 [cited 4 Aug 2013]. Available from:
http://www.fda.gov/RegulatoryInformation/Legislation/ucm149278.htm
5. US Code. Public Health Service Act. Regulations to control communicable diseases. 1999;Title 42, Part 264, Section 361 [cited 4 Aug 2013]. Available from:
http://www.fda.gov/RegulatoryInformation/Legislation/ucm149429.htm